1. 1161Accuracy of non contrast magnetic resonance for clinical diagnosis of cardiac amyloidosis - a 868 patient prospective study. (28th August 2018) Authors: Boldrini, M; Baggiano, A; Naharro, A M; Kotecha, T; Rezk, T; Fayed, H; Knight, D; Moon, J; Kellman, P; Gillmore, J; Hawkins, P; Fontana, M Journal: European heart journal Issue: Volume 39(2018)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A multi-modality, multi-parametric phenotyping study of transthyretin amyloid cardiomyopathy associated with the p.V142I TTR variant. (3rd October 2022) Authors: Razvi, Y; Ioannou, A; Chacko, L; Patel, R; Ganesananthan, S; Kaza, N; Blakeney, I; Porcari, A; Masi, A; Venneri, L; Rauf, M U; Martinez-Naharro, A; Hawkins, P N; Fontana, M; Gillmore, J Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Clinical symptoms and molecular investigations in 13 patients with Schnitzler syndrome identified at the single UK centre. Issue 1 (December 2015) Authors: Rowczenio, D; Trojer, H; Baginska, A; Gillmore, J; Wechalekar, A; Hawkins, P; Lachmann, H Journal: Pediatric rheumatology online journal Issue: Volume 13:Issue 1(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Deletion in MEFV resulting in the loss of p.M694 residue as the cause of autosomal dominant familial Mediterranean fever in North Western European Caucasians - a case series and genetic exploration. Issue 1 (December 2015) Authors: Rowczenio, D; Iancu, D; Trojer, H; Gilbertson, J; Gillmore, J; Wechalekar, A; Tekman, M; Stanescu, H; Kleta, R; Lane, T; Hawkins, P; Lachmann, H Journal: Pediatric rheumatology online journal Issue: Volume 13:Issue 1(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Global longitudinal strain predicts survival and response in patients with systemic AL amyloidosis. analysis of 915 patients from the ALchemy prospective trial. (25th November 2020) Authors: Cohen, O; Ismail, A; Manwani, R; Ravichandran, S; Foard, D; Mahmood, S; Sachchithanantham, S; Martinez-Naharro, A; Fontana, M; Lachmann, H; Hawkins, P; Gillmore, J; Whelan, C; Wechalekar, A.D Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Long-term integrated safety of patisiran in patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy. (25th November 2020) Authors: Gillmore, J; Berk, J; Dispenzieri, A; Polydefkis, M; Gonzalez-Duarte, A; Sekijima, Y; Sweetser, M.T; Arum, S; Wang, J.J; White, M.T; Maurer, M Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Prognostic implications of biventricular uptake of bone tracers at planar scintigraphy in transthyretin cardiac amyloidosis. (3rd October 2022) Authors: Porcari, A; Pagura, L; Canepa, M; Biagini, E; Cappelli, F; Tini, G; Dore, F; Longhi, S; Sciagra', R; Fontana, M; Gillmore, J; Rapezzi, C; Merlo, M; Sinagra, G Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Progression, regression and redefining the treatment response – cardiac magnetic resonance with T1 and extracellular volume mapping in cardiac light-chain amyloidosis. (3rd October 2022) Authors: Patel, R; Martinez-Naharro, A; Kotecha, T; Karia, N; Ioannou, A; Petrie, A; Chacko, L; Razvi, Y; Lachmann, H; Venneri, L; Kellman, P; Gillmore, J; Hawkins, P; Wechalekar, A; Fontana, M Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Regression of cardiac amyloid deposits with novel therapeutics: reaching new frontiers in cardiac ATTR amyloidosis. (25th November 2020) Authors: Chacko, L; Martinez-Naharro, A; Kotecha, T; Martone, R; Hutt, D; Lane, T; Knight, D; Moon, J; Kellman, P; Hawkins, P; Gillmore, J; Fontana, M Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Size matters - redefining sex differences among patients with transthyretin amyloid cardiomyopathy – have we been wrong all along?. (3rd October 2022) Authors: Patel, R; Ioannou, A; Razvi, Y; Chacko, L; Venneri, L; Martinez-Naharro, A; Masi, A; Lachmann, H; Wechalekar, A; Petrie, A; Whelan, C; Hawkins, P; Gillmore, J; Fontana, M Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗